000 | 01834 a2200517 4500 | ||
---|---|---|---|
005 | 20250514020440.0 | ||
264 | 0 | _c20020111 | |
008 | 200201s 0 0 eng d | ||
022 | _a1524-4539 | ||
024 | 7 |
_a10.1161/hc4901.100382 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMacCarthy, P A | |
245 | 0 | 0 |
_aImpaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. _h[electronic resource] |
260 |
_bCirculation _cDec 2001 |
||
300 |
_a2967-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xmetabolism |
650 | 0 | 4 |
_aArginine _xpharmacology |
650 | 0 | 4 |
_aAscorbic Acid _xpharmacology |
650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
650 | 0 | 4 |
_aMetalloporphyrins _xpharmacology |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aNADPH Oxidases _xmetabolism |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aSubstance P _xpharmacology |
700 | 1 | _aGrieve, D J | |
700 | 1 | _aLi, J M | |
700 | 1 | _aDunster, C | |
700 | 1 | _aKelly, F J | |
700 | 1 | _aShah, A M | |
773 | 0 |
_tCirculation _gvol. 104 _gno. 24 _gp. 2967-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/hc4901.100382 _zAvailable from publisher's website |
999 |
_c11652625 _d11652625 |